Subtopic Deep Dive
Oral Manifestations of HIV and HAART
Research Guide
What is Oral Manifestations of HIV and HAART?
Oral manifestations of HIV and HAART refer to changes in HIV-related oral lesions following the introduction of highly active antiretroviral therapy (HAART), including prevalence declines and persistent conditions correlated with viral load and immune reconstitution.
HAART introduction led to reduced rates of oral opportunistic infections in HIV patients (Schmidt‐Westhausen et al., 2000, 170 citations). Studies document decreased frequency of lesions like candidiasis in industrialized countries (Hodgson et al., 2006, 141 citations). About 20 papers track these shifts from 1986 to 2014.
Why It Matters
Tracking HAART's impact on oral lesions proxies systemic HIV control, guiding dental protocols for people living with HIV (PLWH). Oral candidiasis signals esophageal involvement, aiding early intervention (Tavitian et al., 1986, 196 citations). Persistent warts post-HAART indicate HPV risks despite therapy (King et al., 2002, 145 citations). Mycobiome shifts reveal fungal antagonists like Pichia, informing prophylaxis (Mukherjee et al., 2014, 323 citations). These markers support public health monitoring in resource-limited settings.
Key Research Challenges
Persistent Oral Lesions Post-HAART
Certain lesions like HPV warts persist or emerge despite HAART due to incomplete immune recovery (King et al., 2002). Prevalence dropped for most infections but not all (Hodgson et al., 2006). Longitudinal studies needed to correlate with CD4 counts.
Azole-Resistant Candida Strains
Late-presenting AIDS patients show frequent azole-resistant Candida, complicating treatment (Mulu et al., 2013, 127 citations). Diagnosis requires microbiological confirmation beyond clinical signs (Coronado-Castellote and Jimenez-Soriano, 2013). Resistance links to delayed HAART access.
Mycobiome Dysbiosis in HIV
HIV disrupts oral mycobiome, reducing protective Pichia while favoring pathogens (Mukherjee et al., 2014). Pyrosequencing reveals shifts not captured by culture methods. Challenges link microbiota to lesion persistence under HAART.
Essential Papers
Oral Mycobiome Analysis of HIV-Infected Patients: Identification of Pichia as an Antagonist of Opportunistic Fungi
Pranab K. Mukherjee, Jyotsna Chandra, Mauricio Retuerto et al. · 2014 · PLoS Pathogens · 323 citations
Oral microbiota contribute to health and disease, and their disruption may influence the course of oral diseases. Here, we used pyrosequencing to characterize the oral bacteriome and mycobiome of 1...
Oral lesions in infection with human immunodeficiency virus.
Maeve M. Coogan, John S. Greenspan, Stephen Challacombe · 2005 · PubMed · 230 citations
This paper discusses the importance of oral lesions as indicators of infection with human immunodeficiency virus (HIV) and as predictors of progression of HIV disease to acquired immunodeficiency s...
Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-Transplant
Emily W. Bratton, Nada El Husseini, Cody A. Chastain et al. · 2012 · PLoS ONE · 205 citations
The Infectious Disease Society of America (IDSA) 2010 Clinical Practice Guidelines for the management of cryptococcosis outlined three key populations at risk of disease: (1) HIV-infected, (2) tran...
Clinical and microbiological diagnosis of oral candidiasis
L. Coronado-Castellote, Y. Jimenez-Soriano · 2013 · Journal of Clinical and Experimental Dentistry · 197 citations
Introduction: Candidiasis or oral candidiasis is the most frequent mucocutaneous mycosis of the oral cavity. It is produced by the genus Candida, which is found in the oral cavity of 53% of the gen...
Oral Candidiasis as a Marker for Esophageal Candidiasis in the Acquired Immunodeficiency Syndrome
Avedis Tavitian, JEAN-PIERRE RAUFMAN, LINDA E. ROSENTHAL · 1986 · Annals of Internal Medicine · 196 citations
Brief Reports1 January 1986Oral Candidiasis as a Marker for Esophageal Candidiasis in the Acquired Immunodeficiency SyndromeAVEDIS TAVITIAN, M.D., JEAN-PIERRE RAUFMAN, M.D., LINDA E. ROSENTHAL, M.D...
Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy
Andrea M. Schmidt‐Westhausen, Frank Priepke, Frank Bergmann et al. · 2000 · Journal of Oral Pathology and Medicine · 170 citations
Abstract: In recent years the management of human immunodeficiency virus (HIV)‐positive individuals has been based on highly active antiretroviral therapy (HAART) comprising a combination of nucleo...
The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: A UK study
Anwar R. Tappuni, Garry J.P. Fleming · 2001 · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · 161 citations
Reading Guide
Foundational Papers
Start with Coogan et al. (2005, 230 citations) for lesion indicators of HIV progression; Tavitian et al. (1986, 196 citations) for candidiasis as esophageal marker; Schmidt‐Westhausen et al. (2000, 170 citations) for HAART impact baselines.
Recent Advances
Mukherjee et al. (2014, 323 citations) for mycobiome antagonists; Hodgson et al. (2006, 141 citations) for industrialized HAART-era epidemiology; Mulu et al. (2013, 127 citations) for resistance trends.
Core Methods
Pyrosequencing for microbiota (Mukherjee 2014); clinical/microbiological diagnosis (Coronado-Castellote 2013); nested case-control for warts (King 2002); temporal prevalence comparisons (Bratton 2012).
How PapersFlow Helps You Research Oral Manifestations of HIV and HAART
Discover & Search
Research Agent uses searchPapers and citationGraph on 'oral manifestations HAART' to map 20+ papers from Schmidt‐Westhausen (2000) declining infections to Mukherjee (2014) mycobiome shifts. exaSearch uncovers temporal trends; findSimilarPapers links HAART studies to King (2002) warts.
Analyze & Verify
Analysis Agent applies readPaperContent to extract prevalence data from Hodgson (2006), then runPythonAnalysis with pandas to plot lesion rates pre/post-HAART vs. CD4 counts. verifyResponse (CoVe) checks claims against GRADE grading for evidence strength on candidiasis markers (Tavitian, 1986). Statistical verification confirms 70% decline correlations.
Synthesize & Write
Synthesis Agent detects gaps in azole resistance post-HAART studies, flags contradictions between early (Coogan et al., 2005) and recent data. Writing Agent uses latexEditText, latexSyncCitations for review manuscripts, latexCompile for figures, exportMermaid for lesion prevalence timelines.
Use Cases
"Analyze prevalence decline of oral candidiasis pre/post-HAART with stats"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas plot of rates from Schmidt‐Westhausen 2000 and Tappuni 2001) → matplotlib graph of 50-70% drops.
"Draft LaTeX review on HIV oral mycobiome changes under HAART"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Mukherjee 2014, Hodgson 2006) → latexCompile → PDF with cited tables.
"Find code for pyrosequencing analysis of HIV oral mycobiome"
Research Agent → paperExtractUrls (Mukherjee 2014) → Code Discovery → paperFindGithubRepo → githubRepoInspect → QIIME2 pipeline for fungal analysis.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers → citationGraph on HAART lesion declines, outputs structured report with GRADE scores. DeepScan's 7-steps verify mycobiome data (Mukherjee 2014) with CoVe checkpoints. Theorizer generates hypotheses on Pichia's role in HAART-resistant lesions from trend synthesis.
Frequently Asked Questions
What defines oral manifestations of HIV and HAART?
Changes in HIV-related oral lesions post-HAART, with declines in opportunistic infections like candidiasis (Schmidt‐Westhausen et al., 2000) but persistence of warts (King et al., 2002).
What are key methods for studying these manifestations?
Pyrosequencing for mycobiome (Mukherjee et al., 2014); clinical exams and cultures for candidiasis diagnosis (Coronado-Castellote and Jimenez-Soriano, 2013); longitudinal prevalence tracking (Hodgson et al., 2006).
What are landmark papers?
Mukherjee et al. (2014, 323 citations) on mycobiome; Coogan et al. (2005, 230 citations) on lesions as HIV predictors; Schmidt‐Westhausen et al. (2000, 170 citations) on HAART declines.
What open problems remain?
Azole-resistant Candida in late HAART cases (Mulu et al., 2013); HPV warts emergence (King et al., 2002); mycobiome predictors of lesion persistence despite viral suppression.
Research HIV/AIDS oral health manifestations with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Oral Manifestations of HIV and HAART with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers